Company Filing History:
Years Active: 1978
Title: Innovations of Robert W. Sidwell
Introduction
Robert W. Sidwell is a notable inventor based in Irvine, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. His work has implications for the synthesis of bioactive compounds, showcasing his innovative approach to medicinal chemistry.
Latest Patents
One of Robert W. Sidwell's key patents is titled "9.beta.-D-Arabinofuranosylpurine nucleotides and method of use." This patent describes a novel structure of 9-.beta.-D-Arabinofuranosyl nucleotides, which exhibit antiviral activity in vitro. The compounds prepared according to this invention are not only effective against viruses but also serve as precursors for the synthesis of other bioactive compounds. This patent highlights his expertise in creating effective pharmaceutical agents.
Career Highlights
Robert W. Sidwell has been associated with Icn Pharmaceuticals, Inc., where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of nucleotides and their applications in antiviral therapies. With a patent portfolio that includes 1 patent, he has established himself as a key figure in his field.
Collaborations
Throughout his career, Robert has collaborated with notable colleagues such as Richard L. Tolman and Ganapathi R. Revankar. These collaborations have further enriched his research and contributed to the development of innovative solutions in the pharmaceutical industry.
Conclusion
Robert W. Sidwell's contributions to the field of pharmaceuticals through his innovative patents and collaborations underscore his importance as an inventor. His work continues to influence the development of antiviral therapies and bioactive compounds.